Clinical Trial Update: Effect of Food of NTQ5082 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the effect of food on NTQ5082 in healthy subjects; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complement-mediated Hemolytic Diseases

Drugs mentioned

• NTQ5082

Snippet

Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Conditions: Complement-mediated Hemolytic Diseases | Phase 1 | Status: NOT_YET_RECRUITING